LivaNova (LIVN) EPS (Basic) (QoQ) (2015 - 2026)
LivaNova (LIVN) EPS (Basic) (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn |
| 10 | LivaNova | 4.33 Bn | 3.81 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 367.16% |
| Mar 31, 2026 | -25.33% |
| Dec 31, 2025 | 15.54% |
| Sep 30, 2025 | -1.46% |
| Jun 30, 2025 | 108.28% |
| Mar 31, 2025 | -683.66% |
| Dec 31, 2024 | 70.15% |
| Sep 30, 2024 | 100.75% |
| Jun 30, 2024 | 138.87% |
| Mar 31, 2024 | -355.95% |
| Dec 31, 2023 | 324.69% |
| Sep 30, 2023 | -713.77% |
| Jun 30, 2023 | -84.06% |
| Mar 31, 2023 | 336.51% |
| Dec 31, 2022 | 101.58% |
| Sep 30, 2022 | -751.13% |
| Jun 30, 2022 | 441.64% |
| Mar 31, 2020 | -630.59% |
| Dec 31, 2018 | -13.38% |
| Sep 30, 2018 | 79.80% |